1,000
Participants
Start Date
November 24, 2022
Primary Completion Date
December 30, 2024
Study Completion Date
December 31, 2025
Solid tumor patients receiving immunotherapy for the first time were included in the study
Solid tumor patients receiving immunotherapy were included in the study. Baseline information before treatment (including demographic characteristics, basic diseases and their medication history, tumor and anti-tumor history, quality of life scores, etc.) and follow-up information after treatment (PFS, OS, etc.) were collected to summarize factors that may affect the efficacy and prognosis of patients receiving immunotherapy
First Affiliated Hospitap of Xian Jiaotong University, Xi’an
First Affiliated Hospital Xi'an Jiaotong University
OTHER